Traducción automática para su comodidad. Para decisiones médicas, confirme los detalles con nuestro equipo bilingüe.

Peptide Therapy

Physician-Supervised Peptide Therapy

Evidence, sourcing and supervision first. A clear, evidence-aware guide to candidacy, treatment, recovery, limitations and next steps.

Evidence reviewed July 30, 2026
Confident mature man in a refined precision-wellness setting

Precision Wellness

Care designed around how you want to feel and perform

Your symptoms, health history, laboratory data and long-term goals shape the conversation from the beginning.

The Short Answer

What is Physician-Supervised Peptide Therapy?

A peptide is a short chain of amino acids. Some peptide medicines are FDA-approved for specific diseases; many products promoted online for anti-aging, healing, muscle gain or weight loss are investigational, unapproved or labeled “research use only.” Therapy should begin with diagnosis and product-specific evidence—not a peptide trend.

Candidacy

Who may—or may not—be a candidate

Who may be considered

Candidacy exists only when a licensed clinician identifies a legitimate clinical goal, an evidence-supported product or carefully justified compounded need, and a monitoring plan. The fact that a substance is a peptide does not make it safe or appropriate.

When treatment may not be appropriate

Do not use products sold without a valid prescription, labeled for research use only, shipped from unknown sources or promoted with guaranteed cures. Pregnancy, cancer risk, endocrine disease, medication interactions and organ dysfunction may change suitability depending on the specific drug.

At a Glance

Treatment facts

These are practical planning ranges, not promises. Your consultation determines the exact plan.

Treatment Time

Consultation usually 30–60 minutes

Comfort / Anesthesia

No anesthesia for consultation; treatment route depends on the approved product

Typical Downtime

None for consultation; adverse effects are product-specific

When Changes May Appear

No universal timeline—depends on diagnosis, evidence and medication

How Long Results May Last

Only while benefit, safety and legal access justify treatment

Treatments Commonly Considered

Individualized follow-up and laboratory monitoring

Your Visit

What happens during treatment

01

Evaluate

A physician reviews symptoms, diagnoses, medicines, goals and whether established treatments should come first.

02

Plan & treat

The exact molecule, FDA status, human evidence, risks, pharmacy and legal availability are reviewed. “Peptide” is never treated as one category of efficacy.

03

Review & follow up

If a legitimate therapy is appropriate, prescription, monitoring and stopping rules are documented. Patients are directed to the Peptide Education Center for deeper evidence.

Informed Choice

Important risks, limitations and alternatives

Risks & limitations

Unknown-source products may be counterfeit, contaminated, incorrectly dosed, nonsterile or a different substance entirely. Potential harm includes infection, allergic reaction, endocrine disruption, blood-sugar changes, organ injury, tumor-related concerns and permanent harm. Compounded drugs are not FDA-approved and do not undergo premarket review for safety, effectiveness or quality.

Alternatives to discuss

  • An FDA-approved treatment with stronger evidence
  • Diagnosis-specific care through primary care or a specialist
  • Nutrition, sleep, rehabilitation or hormone evaluation when appropriate
  • No treatment when evidence is inadequate or sourcing cannot be verified

Clinical Judgment

Why provider experience matters

A well-versed physician distinguishes an approved medication from a marketing label, verifies the pharmacy and prescription pathway, monitors measurable outcomes and refuses products whose evidence or source does not support safe care.

Access & Cost

In-office versus telehealth

Consultations and appropriate follow-up may be in-office or by telehealth for patients physically located in Texas, North Carolina or South Carolina, subject to law and clinical eligibility. Labs or in-person examination may be required.

Pricing: Consultation required. Cost depends on the evaluation, tests, legally available medication, pharmacy and follow-up. No specific peptide or prescription is guaranteed.

Go Deeper

Visit the Peptide Education Center

Review FDA-approved peptide medicines, investigational compounds, sourcing safeguards, evidence grading and individual peptide guides.

Common Questions

Physician-Supervised Peptide Therapy FAQ

No. Approval applies to a specific product and indication. Many peptides promoted online are investigational or unapproved for human use.

No. Compounded medicines are not FDA-approved and do not undergo FDA premarket review. They may be appropriate only in limited patient-specific circumstances under applicable law.

Confirm state pharmacy licensure, the dispensing pharmacy name and address, the prescription label, prescriber relationship and whether the product came through a legitimate patient-specific prescription. Avoid sellers that hide the source or require no prescription.

Use Identity Aesthetics’ Peptide Education Center for FDA-status distinctions, research-only compounds, sourcing checks and individual evidence guides.

Sources & Medical Review

Evidence behind your treatment guide